Predict your next investment

Venture Capital
bioeconomycapital.com

See what CB Insights has to offer

Investments

17

Portfolio Exits

1

Funds

2

About Bioeconomy Capital

Bioeconomy Management has been established to assist selected startup companies in the space grow from their core of a couple of founders in a lab to a $50M company.

Bioeconomy Capital Headquarter Location

3417 Evanston Ave N Suite 329

Seattle, Washington, 98103,

United States

206-992-7901

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Bioeconomy Capital

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Bioeconomy Capital in 1 Expert Collection, including Synthetic Biology.

S

Synthetic Biology

382 items

Latest Bioeconomy Capital News

Tandem PV Secures $6 Million Funding

May 2, 2022

Tandem PV Secures $6 Million Funding Wednesday 20th April 2022 US start-up gets funding to manufacture first commercial grade tandem perovskite solar panels Tandem PV, a California-based photovoltaic technology company specialiding in ultra high-efficiency tandem perovskite solar panels, today announced the initial $6 million close of its $12 million Series A financing round. The round was led by Bioeconomy Capital, an early-stage venture capital firm, through its new Planetary Technologies fund, with participation from an international solar manufacturer and a US utility company. Tandem PV will use the funds to build a pilot manufacturing facility in San Jose, CA, enabling the company to enter its next phase of growth in producing commercial-grade solar panels. “Our mission is to find scalable Planetary Technologies that can help the world mature beyond fossil fuels at the pace necessary to avoid unsustainable warming,” said Rik Wehbring, a managing director of Bioeconomy Capital and a board member at Tandem PV. “Tandem PV is commercialising transformative technology that achieves this goal.” Tandem PV was co-founded by materials science PhD Colin Bailie and solar industry pioneer Chris Eberspacher, with the mission to achieve 50 percent of energy generation from solar by 2050. This can be realized in part by enabling net zero energy buildings and the electrification of everything at the residential and micro-grid scale to meet a core need for 50 million residential households in the US alone. “We have tremendous market pull from residential solar installers, end users, equipment distributors and utilities - the industry is ready for more sustainable, efficient and cost-effective solar panels,” said Colin Bailie, co-founder and CEO of Tandem PV. To create greater value for solar energy at the terawatt scale, Tandem PV transforms silicon solar panels into high-efficiency tandems by leveraging perovskite-coated front glass via a drop-in manufacturing replacement. Bailie developed this unique design during his doctorate at Stanford University, earning recognition in Forbes' 30 Under 30 in the energy sector in 2016. This solar panel technology is poised to offer 50 percent higher efficiency than the average solar panel and drive solar system costs down by 30 percent or more. “The cost and performance improvements expected by Tandem PV's technology will enable substantially higher photovoltaic penetration worldwide, potentially offsetting three gigatons of CO2 equivalent per year,” said Chris Eberspacher, co-founder and managing director of Tandem PV. “Tandem PV is on a fast track to develop, demonstrate and commercialise perovskite and silicon tandem solar panels for homes across the United States and worldwide.” CS International to return to Brussels – bigger and better than ever! The leading global compound semiconductor conference and exhibition will once again bring together key players from across the value chain for two-days of strategic technical sessions, dynamic talks and unrivalled networking opportunities. Join us face-to-face between 28th – 29th June 2022

Bioeconomy Capital Investments

17 Investments

Bioeconomy Capital has made 17 investments. Their latest investment was in SunTrain as part of their Seed VC on April 4, 2022.

CBI Logo

Bioeconomy Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

4/7/2022

Seed VC

SunTrain

$0.75M

Yes

1

2/15/2022

Series B

Parse Biosciences

$41.5M

No

6

2/9/2022

Series A

Tandem PV

$6M

Yes

2

1/24/2022

Series A

Subscribe to see more

$99M

Subscribe to see more

10

7/22/2021

Series B

Subscribe to see more

$99M

Subscribe to see more

10

Date

4/7/2022

2/15/2022

2/9/2022

1/24/2022

7/22/2021

Round

Seed VC

Series B

Series A

Series A

Series B

Company

SunTrain

Parse Biosciences

Tandem PV

Subscribe to see more

Subscribe to see more

Amount

$0.75M

$41.5M

$6M

$99M

$99M

New?

Yes

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

6

2

10

10

Bioeconomy Capital Portfolio Exits

1 Portfolio Exit

Bioeconomy Capital has 1 portfolio exit. Their latest portfolio exit was Bellwether Bio on March 27, 2019.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

3/27/2019

Acquired

$99M

1

Date

3/27/2019

Exit

Acquired

Companies

Valuation

$99M

Acquirer

Sources

1

Bioeconomy Capital Fund History

2 Fund Histories

Bioeconomy Capital has 2 funds, including Bioeconomy Fund 1.

Closing Date

Fund

Fund Type

Status

Amount

Sources

9/14/2017

Bioeconomy Fund 1

Early-Stage Venture Capital

Closed

$5M

1

Bioeconomy Mbyre

Subscribe to see more

Subscribe to see more

10

Closing Date

9/14/2017

Fund

Bioeconomy Fund 1

Bioeconomy Mbyre

Fund Type

Early-Stage Venture Capital

Subscribe to see more

Status

Closed

Subscribe to see more

Amount

$5M

Sources

1

10

Bioeconomy Capital Team

3 Team Members

Bioeconomy Capital has 3 team members, including current Chief Executive Officer, Spencer Adler.

Name

Work History

Title

Status

Spencer Adler

Chief Executive Officer

Current

Robert Carlson

World Health Organization, NAS, and The Hastings Center

Managing Director

Current

Rik Wehbring

Managing Director

Current

Name

Spencer Adler

Robert Carlson

Rik Wehbring

Work History

World Health Organization, NAS, and The Hastings Center

Title

Chief Executive Officer

Managing Director

Managing Director

Status

Current

Current

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.